AtTEnd/ENGOT-EN7

Trial Description: 
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with paclitaxel and carboplatin in women with advanced/recurrent endometrial cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Endometrial
Trial Status: 
Recruiting
Contact person: